Skip to main content
OpenTrials
Completed

NCT Number: NCT06751147

Effects of Lateral Femoral Cutaneous Nerve Mobilization With and Without Muscle Energy Techniques in Pregnant Females

The rationale of this study is to provide empirical evidence regarding the efficacy and safety of neural mobilization in pregnant women with meralgia paresthetica. By investigating the potential benefits of this intervention, healthcare professionals can make informed decisions about incorporating neural mobilization into the management of this condition during pregnancy. Focusing on the impact of neural mobilization and muscle energy techniques on both neuropathic pain and quality of life aligns with a patient-centered approach to care. The goal is not only to reduce symptoms but also to enhance overall well-being and functional capacity

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Meralgia Paresthetica Femoral Neuropathy Mononeuropathies Nervous System Diseases Neuromuscular Diseases Peripheral Nervous System Diseases

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ghurkhi Hospital, Lahore, Punjab Province, Pakistan

Loading trial locations.

About this study

The literature gap of the study is that upto our knowledge, there is little or no evidence found in previous researches on the combined effects of lateral femoral cutaneous nerve mobilization in combination with MET in pregnant females. Secondly no quantitative measurement as range of motion with goniometer has been yet studied

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ranges from 18 to 40 years
  • Body mass index ≥25kg/m2.
  • Pregnant females in third trimester diagnosed with myalgia paraesthetica.
  • Multigravida pregnant females
  • Patients will be screened through Prone Knee Bend (PKB) test for femoral nerve compression.
  • Positive pelvic compression test(1)

Exclusion criteria

  • Those having other entrapment syndromes or radicular symptoms
  • Motor weakness
  • Having a history or ongoing cancerous proliferation
  • Active infection

Treatment and study plan

Group A

Other

It consists of 24 patients who were assessed by prone knee bend (PKB) test and knee range of motion was measured by goniometer. In addition to traditional physical therapy and muscle energy procedures, patients in this group received neural mobilization. The patient laid on their side with their knee bent to a 90-degree angle and the affected side looking up while neural mobilization was carried out. The therapist then performed the technique by abducting and extending the patient's hip. Five repetitions of the nerve stretch were performed, each with a 10-second hold and a 5-second rest in between.

METs were implemented in two positions using post-isometric relaxation (PIR): In this initial posture, the patient laid on their back with the affected leg just over the bed's edge. With one hand, the physiotherapist stood facing the affected side and pressed the contralateral ASIS to keep the patient from rolling off the bed. The therapist, however, simultaneously grabbed the femur dist

Experimental Group B

Other

It involves 24 patients who had received the neural mobilization described above along with traditional physical therapy that does not involve muscular energy techniques. The treatment took place in the outpatient physical therapy department and lasted around thirty minutes in total

Primary outcomes

  1. quality of life is assessed by QOL questioner

    Time frame: at base line pre intervention, at the end of 4th week post intervention

    EQ-5D is used to measure quality of life

  2. Knee range of motion is used to measure ROM

    Time frame: at base line pre intervention, at the end of 4th week post intervention

    measured by goniometer

  3. neuropathic pain

    Time frame: at base line pre intervention, at the end of 4th week post intervention

    The Neuropathic Pain Scale (NPS) is a tool used to assess the specific qualities of pain associated with neuropathic pain. It helps differentiate neuropathic pain from other types of pain by evaluating different pain sensations and their intensity. The NPS consists of 10 items, each rated on a scale of 0 to 10, where 0 is "no pain" and 10 is the "worst imaginable pain".

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Effects of Lateral Femoral Cutaneous Nerve Mobilization With and Without Muscle Energy Techniques on Neuropathic Pain, Knee Range of Motion and Quality of Life in Pregnant Females

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Dec 27, 2024
Registry last updated
Jul 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.